Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score
Clinical trial NCT02236572 · TERMINATED
Trial details
- NCT number
- NCT02236572
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-29
- Primary completion
- 2021-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.